Two-Year Outcomes Reported from the FDA Regulated Pilot Study of the Spinal Restoration, Inc. Biostat(R) System

AUSTIN, Texas--(BUSINESS WIRE)--Spinal Restoration, Inc. announced today that the final 2-year outcomes from the 15 patient FDA regulated pilot study of the Biostat System were presented by Dr. Way Yin on Friday, August 12th at the Annual Meeting of the International Spine Intervention Society (ISIS). The study demonstrated that the encouraging outcomes reported at the 6-month primary endpoint were well maintained through the final 2-year evaluation.